Wednesday | 28 September 2022 | 16:45–17:15

Session 5 | Computational Design and GPCR Therapeutics
Variation in GPCR Signaling: Implications for Physiology and Drug Discovery

Monday | 26 September 2022 | 14:30–15:00

Session 1 | Modulations of GPCR Signal Transduction
Mu-opioid receptor induced changes in beta-arrestin2 conformations

Tuesday | 27 September 2022 | 11:30–12:00

Session 2 | Holistic Concepts in GPCR Signal Transduction
Dual-activity GPCR: ACKR3 at the crossroads between chemokine and opioid peptide regulation

Wednesday | 28 September 2022 | 14:30–15:00

Session 4 | GPCR in Physiology and Disease
GPCRs and metabolic disease

Wednesday | 28 September 2022 | 14:00–14:30

Session 4 | GPCR in Physiology and Disease
Targeting GPCRs to enhance haematopoietic stem cell transplantation

Tuesday | 27 September 2022 | 14:30–15:00

Session 3 | Physiology
GPR133 (ADGRD1) signaling is increased by the dissociation of its extracellular NTF and by binding of its new positive allosteric modulator PTK7

Tuesday | 27 September 2022 | 09:00–09:30

Session 2 | Holistic Concepts in GPCR Signal Transduction
Role of GPCRs in regulation of hormone and neurotransmitter release

Wednesday | 28 September 2022 | 16:15–16:45

Session 5 | Computational Design and GPCR Therapeutics
Partial agonism in the picture

Thursday | 29 September 2022 | 16:15–17:30

Keynote Lecture
The role of protein dynamics in G protein coupled receptor activation

 

Tuesday | 27 September 2022 | 11:00–11:30

Session 2 | Holistic Concepts in GPCR Signal Transduction
Deciphering structural design principles for interaction specificity in G protein signaling

 

Monday | 26 September 2022 | 16:30–17:00

Session 1 | Modulations of GPCR Signal Transduction
A Simple and Obvious (in Retrospect) Method for Microscopy Imaging of G-protein Signaling

 

Tuesday | 27 September 2022 | 16:15–16:45

Session 3 | Physiology
In vivo investigations of adhesion GPCR function

Thursday | 29 September 2022 | 09:00–09:30

Session 5 | Computational Design and GPCR Therapeutics
Application of computational methods in rational design of multi-target ligands as potential antipsychotics and antidepressants

Wednesday | 28 September 2022 | 11:15–11:45

Session 4 | GPCR in Physiology and Disease
How come that GIPR agonists and antagonists both result in weight loss?

Thursday | 29 September 2022 | 09:30–10:00

Session 5 | Computational Design and GPCR Therapeutics
Integrated computational and structural approaches for GPCR drug discovery

Monday | 26 September 2022 | 17:00–17:30

Session 1 | Modulations of GPCR Signal Transduction
Mechanism of Class F receptor activation and signal specification

 

Thursday | 29 September 2022 | 14:00–14:30

Session 6 | Molecular Structure and Dynamics
Structural insights into GPCR-beta-arrestin interaction and signaling

 

Wednesday | 28 September 2022 | 09:00–10:15

Keynote Lecture
Adhesion-GPCR signaling in synapse formation

 

Tuesday | 27 September 2022 | 14:00–14:30

Session 3 | aGPCR: from Structure to Function
Ligands identification and Structural studies of several aGPCRs

 

Tuesday | 27 September 2022 | 09:30–10:00

Session 2 | Holistic Concepts in GPCR Signal Transduction
GPCR-mediated endosomal ERK signaling through G proteins: implications to disease

 

Thursday | 29 September 2022 | 11:30–12:00

Session 6 | Molecular Structure and Synamics
Structural insights into allostery in GPCRs: G proteins, arrestin and dimers

 

Monday | 26 September 2022 | 15:00–15:30

Session 1 | Modulations of GPCR Signal Transduction
Toward understanding the subcellular organization and reorganization of GPCR signaling

 

Wednesday| 28 September 2022 | 10:45–11:15

Session 4 | GPCR in Physiology and Disease
Orphan GPCRs in the vascular and immune systemg